EU panel backs Darzalex for high-risk smoldering multiple myeloma
A European Medicines Agency (EMA) committee recommended that…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
When words fail: The silence that falls after a myeloma diagnosis
I still remember what happened in 2022 after my…
Combination myeloma treatment shows promise in trial
Most people with hard-to-treat multiple myeloma who were…
Why I continue to write about my experience as a caregiver
“Nobody is reading any of those essays you caregivers…
Patients in cell therapy Carvykti trial in remission after 5 years
One-third of patients with hard-to-treat myeloma were alive…
Turning our darkness into someone else’s light
When I recently read that former U.S. President Joe…
